Price
Financials
Standalone, Rs crore| Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 13.14 | 14.09 | 10.18 | 11.82 | 12.35 | 10.53 | 13.99 | 13.12 | 12.42 |
| Expenses | 9.52 | 8.93 | 8.54 | 8.48 | 9.24 | 7.93 | 11.53 | 10.58 | 10.12 |
| Operating Profit | 3.62 | 5.16 | 1.64 | 3.34 | 3.11 | 2.60 | 2.46 | 2.54 | 2.30 |
| OPM % | 27.55% | 36.62% | 16.11% | 28.26% | 25.18% | 24.69% | 17.58% | 19.36% | 18.52% |
| Other Income | 0.39 | 0.33 | 3.00 | 1.52 | -5.29 | 1.03 | 1.22 | 1.17 | 0.29 |
| Interest | 0.95 | 1.03 | 1.19 | 0.98 | 1.20 | 0.88 | 1.26 | 0.88 | 1.07 |
| Depreciation | 0.87 | 1.44 | 1.66 | 1.28 | 1.59 | 1.34 | 1.07 | 0.92 | 0.98 |
| Profit before tax | 2.19 | 3.02 | 1.79 | 2.60 | -4.97 | 1.41 | 1.35 | 1.91 | 0.54 |
| Tax % | 61.19% | 23.51% | 31.28% | 26.15% | 3.62% | 21.99% | 34.81% | 24.61% | 87.04% |
| Net Profit | 0.86 | 2.32 | 1.22 | 1.92 | -5.15 | 1.10 | 0.88 | 1.43 | 0.07 |
| EPS in Rs | 0.62 | 1.67 | 0.88 | 1.38 | -3.71 | 0.79 | 0.63 | 1.03 | 0.05 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales | 20.07 | 21.41 | 20.38 | 29.66 | 24.27 | 24.18 | 24.53 | 25.54 |
| Expenses | 12.23 | 13.78 | 11.49 | 20.25 | 17.47 | 17.74 | 19.47 | 20.70 |
| Operating Profit | 7.84 | 7.63 | 8.89 | 9.41 | 6.80 | 6.44 | 5.06 | 4.84 |
| OPM % | 39.06% | 35.64% | 43.62% | 31.73% | 28.02% | 26.63% | 20.63% | 18.95% |
| Other Income | 0.37 | 0.01 | 1.06 | 0.40 | 3.33 | -3.76 | 2.25 | 1.46 |
| Interest | 4.75 | 3.74 | 3.46 | 2.66 | 2.22 | 2.18 | 2.14 | 1.96 |
| Depreciation | 3.24 | 3.19 | 3.18 | 2.63 | 3.10 | 2.87 | 2.41 | 1.90 |
| Profit before tax | 0.22 | 0.71 | 3.31 | 4.52 | 4.81 | -2.37 | 2.76 | 2.44 |
| Tax % | 0.00% | 0.00% | 30.21% | 41.15% | 26.40% | 36.29% | 28.26% | 38.11% |
| Net Profit | 0.22 | 0.71 | 2.30 | 2.66 | 3.54 | -3.23 | 1.98 | 1.51 |
| EPS in Rs | 0.22 | 0.72 | 2.32 | 1.91 | 2.55 | -2.32 | 1.42 | 1.09 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 5% | 2% | 4% | ||
| Compounded Profit Growth | % | -5% | -19% | -8% | ||
| Stock Price CAGR | % | % | -26% | -33% | ||
| Return on Equity | % | 3% | 2% | 3% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9.90 | 9.90 | 9.90 | 13.90 | 13.90 | 13.90 | 13.90 | 13.90 |
| Reserves | 0.41 | 1.13 | 3.43 | 52.00 | 55.54 | 52.31 | 54.28 | 55.79 |
| Borrowings | 32.16 | 34.35 | 38.04 | 19.29 | 10.93 | 12.44 | 11.11 | 11.17 |
| Other Liabilities | 0.58 | -0.17 | 2.37 | 3.29 | 4.03 | 3.90 | 3.65 | 3.14 |
| Total Liabilities | 43.05 | 45.21 | 53.74 | 88.48 | 84.40 | 82.55 | 82.94 | 84.00 |
| Fixed Assets | 23.28 | 20.10 | 19.92 | 20.46 | 21.39 | 17.95 | 16.33 | 14.91 |
| CWIP | 0.00 | 0.00 | 0.23 | 3.81 | 0.00 | 0.04 | 0.15 | 0.15 |
| Investments | 0.53 | 0.53 | 0.27 | 0.00 | 0.00 | 0.00 | 20.00 | 20.00 |
| Other Assets | 19.24 | 24.58 | 33.32 | 64.21 | 63.01 | 64.56 | 46.46 | 48.94 |
| Total Assets | 43.05 | 45.21 | 53.74 | 88.48 | 84.40 | 82.55 | 82.94 | 84.00 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 8.95 | 4.62 | 4.35 | 7.83 | 10.97 | 5.52 | 2.36 | 1.67 |
| Cash from Investing Activity | 1.00 | -0.01 | -3.22 | -35.74 | -0.29 | -10.60 | -0.21 | 0.06 |
| Cash from Financing Activity | -5.81 | -1.56 | -1.22 | 28.72 | -10.37 | -0.49 | -3.10 | -1.63 |
| Net Cash Flow | 4.14 | 3.05 | -0.10 | 0.80 | 0.32 | -5.57 | -0.95 | 0.10 |
| Free Cash Flow | 9.95 | 4.61 | 1.13 | 1.36 | 11.02 | 4.88 | 1.49 | 1.19 |
| CFO/OP | 114% | 61% | 49% | 96% | 162% | 129% | 78% | 55% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 102.03 | 92.57 | 97.25 | 65.96 | 90.69 | 7.85 | 18.90 | 31.73 |
| Inventory Days | 16.98 | 12.88 | 18.17 | 25.99 | ||||
| Days Payable | 116.72 | -25.76 | 213.05 | 135.84 | ||||
| Cash Conversion Cycle | 2.29 | 131.22 | -97.64 | -43.89 | 90.69 | 7.85 | 18.90 | 31.73 |
| Working Capital Days | 256.25 | 291.69 | -189.31 | 54.52 | 43.46 | 243.18 | -13.39 | 33.58 |
| ROCE % | 10.13% | 13.99% | 10.09% | 8.17% | 7.95% | 6.17% | 5.99% |
| Nov 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 71.22% | 71.22% | 71.22% | 71.22% | 62.79% | 57.04% | 57.04% | 57.04% | 57.04% | 57.04% | 57.04% | 57.04% |
| Public | 28.78% | 28.79% | 28.78% | 28.78% | 37.21% | 42.96% | 42.96% | 42.96% | 42.96% | 42.96% | 42.96% | 42.96% |
| No. of Shareholders | 2,940 | 2,791 | 2,516 | 2,440 | 2,777 | 2,844 | 2,790 | 2,581 | 2,489 | 2,437 | 2,362 | 2,359 |
Fundamentals
Market Cap₹ 17.4 Cr.
Current Price₹ 12.6
Stock P/E9.80
Book Value₹ 50.1
ROCE5.99 %
ROE2.58 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)4%
Compounded Profit Growth (TTM)-8%
Standalone figures.
Valuation
Market capRs 18 Cr
Enterprise valueRs 28 Cr
Price to book0.27x
Price to sales0.74x
EV / EBITDA10.27x
EV / sales1.14x
Price to cash flow3.25x
Earnings yield-18.01%
P/E, 3-year average15.32x
P/B, 3-year average0.65x
P/E, 5-year average15.32x
P/B, 5-year average0.65x
Profitability
Operating margin (excl. other income)26.63%
Operating margin (incl. other income)11.08%
EBITDA margin11.08%
Pre-tax margin-9.80%
Net profit margin-13.36%
ROE-4.76%
ROCE-0.24%
ROA-3.87%
ROE, 3-year average2.39%
ROCE, 3-year average6.26%
ROA, 3-year average1.32%
ROE, 5-year average6.54%
ROCE, 5-year average8.58%
ROA, 5-year average2.04%
ROIC (approx.)-0.34%
Tax rate-36.29%
Other income / net worth-5.68%
Growth
Sales growth (latest year)-0.37%
Profit growth (latest year)-191.24%
Sales CAGR, 3 years5.86%
Sales CAGR, 5 years3.80%
Per share
EPS (TTM)Rs -2.32
EPS (latest year)Rs -2.32
EPS, 3-year averageRs 0.71
EPS, 5-year averageRs 1.04
Book value per shareRs 47.63
Sales per shareRs 17.40
Cash flow per shareRs 3.97
Free cash flow per shareRs 0.86
Efficiency
Asset turnover0.29x
Fixed asset turnover1.35x
Inventory turnover13.23x
Inventory days28 days
Debtor days8 days
Debtors turnover46.50x
Creditor days136 days
Cash conversion cycle32 days
Working capital days34 days
Leverage
Total debtRs 12 Cr
Cash and bankRs 3 Cr
Net debtRs 10 Cr
Debt to equity0.19x
Net debt / EBITDA3.58x
Interest coverage-0.09x
Owners' fund to total sources80.21%
Debt to assets15.07%
Cash flow
Cash from Operating Activity (latest year)Rs 6 Cr
Cash from Investing Activity (latest year)Rs -11 Cr
Cash from Financing Activity (latest year)Rs -0 Cr
Net Cash Flow (latest year)Rs -6 Cr
Free cash flow (latest year)Rs 1 Cr
FCFE (approx.: FCF + change in debt)Rs 3 Cr
Cash from ops / profit, 5 years4.39x
Sales to cash flow4.38x
Statement figures
Net sales (TTM)Rs 24 Cr
Net sales (latest year)Rs 24 Cr
Operating profit excl. other income (latest year)Rs 6 Cr
Other income (TTM)Rs -4 Cr
EBITDA (TTM)Rs 3 Cr
PBDT (TTM)Rs 0 Cr
Profit before tax (TTM)Rs -2 Cr
Tax (latest year)Rs 1 Cr
Net profit (TTM)Rs -3 Cr
Net profit (latest year)Rs -3 Cr
Depreciation (TTM)Rs 3 Cr
Interest (TTM)Rs 2 Cr
Cost of goods sold (latest year)Rs 4 Cr
Total expenditure (latest year)Rs 18 Cr
Total income (latest year)Rs 20 Cr
Share capitalRs 14 Cr
ReservesRs 52 Cr
Shareholders' fundsRs 66 Cr
Total assetsRs 83 Cr
Net blockRs 18 Cr
Capital work in progressRs 0 Cr
ReceivablesRs 1 Cr
InventoryRs 0 Cr
Other liabilitiesRs 4 Cr
Shares outstanding (crore)1.39
Ownership
Promoter holding57.04% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/B 0.27 is at the 3th percentile (median 2.82).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | NIDAN | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -1.9% | -2.8% | +0.9 pts |
| 1 month | -2.3% | -6.8% | +4.5 pts |
| 3 months | -7.2% | -7.6% | +0.4 pts |
| 6 months | -21.8% | +0.4% | -22.2 pts |
| 1 year | -35.3% | -9.9% | -25.4 pts |
| 2 years | -63.1% | -13.6% | -49.6 pts |
| 3 years | -58.5% | +14.2% | -72.6 pts |
Red flags
F-score 4 of 8| explain | Share dilution Share count up 0% in a year, 40% in three |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Mar 2026Sales ₹12 Cr +0.6% vs Mar 2024.
Net profit ₹0 Cr +101.4%.
Against our estimate for Mar 2026: sales -25.4%, profit -95.0% in line.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Dr Lal Pathlabs Ltd | 32,737 | 58.2 | 28.0 % |
| Vijaya Diagnostic Centre Ltd | 15,192 | 81.0 | 20.5 % |
| Metropolis Healthcare Ltd | 11,665 | 56.0 | 17.8 % |
| Thyrocare Technologies Ltd | 8,708 | 48.2 | 35.4 % |
| Nephrocare Health Services Ltd | 6,671 | 78.4 | 15.3 % |
| Suraksha Diagnostic Ltd | 1,847 | 51.6 | 17.3 % |
| Krsnaa Diagnostics Ltd | 1,791 | 18.1 | 12.7 % |
| 3B Blackbio DX Ltd | 1,396 | 25.1 | 25.5 % |
| One Global Service Provider Ltd | 1,046 | 14.1 | 87.0 % |
| Health X Platform Ltd | 923 | 0.03 % | |
| Gaudium IVF and Women Health Ltd | 830 | 35.9 | 29.3 % |
| Chandan Healthcare Ltd | 581 | 22.1 | 23.3 % |
| Pramodini Medicare Ltd | 259 | 14.9 | 41.8 % |
| Aspira Pathlab & Diagnostics Ltd | 148 | 2.84 % | |
| Choksi Laboratories Ltd | 132 | 69.2 | 9.44 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Less than 100 unique PAN traded in previous 30 daysMandatory Market making period in SME scrip is overSME scrip is not regularly traded
Quick answers
What is the market cap of Nidan Laboratories & Healthcare Ltd?
Nidan Laboratories & Healthcare Ltd (NIDAN) has a market capitalisation of Rs 17.4 Cr. at the 2026-10-01 close.
What is the P/E ratio of Nidan Laboratories & Healthcare Ltd?
Nidan Laboratories & Healthcare Ltd trades at a P/E of 9.80 on trailing twelve-month profit, at the 2026-10-01 close.
What were Nidan Laboratories & Healthcare Ltd's latest quarterly results?
In the Mar 2026 quarter, Nidan Laboratories & Healthcare Ltd sales was Rs 12 Cr (+0.6% vs Mar 2024) and net profit was Rs 0 Cr.
What is the 52-week high and low of Nidan Laboratories & Healthcare Ltd?
The 52-week high is Rs 24.90 and the 52-week low is Rs 11.50.